Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
over-expression causes apoptosis-like cell death which is dependent on the kinase activity. Zusätzlich bieten wir Ihnen serine/threonine Kinase 17b Proteine (10) und serine/threonine Kinase 17b Kits (4) und viele weitere Produktgruppen zu diesem Protein an.
Showing 10 out of 111 products:
Human Polyclonal STK17B Primary Antibody für IF, IHC (p) - ABIN1882073
Sanjo, Kawai, Akira: DRAKs, novel serine/threonine kinases related to death-associated protein kinase that trigger apoptosis. in The Journal of biological chemistry 1998
Show all 3 Pubmed References
Human Polyclonal STK17B Primary Antibody für WB - ABIN252640
Friedrich, Wen, Bain, Kee, Katayama, Murre, Hedrick, Walsh: DRAK2, a lymphoid-enriched DAP kinase, regulates the TCR activation threshold during thymocyte selection. in International immunology 2005
Human Polyclonal STK17B Primary Antibody für ELISA, WB - ABIN4306258
Friedrich, Cui, Hernandez, Weist, Andersen, Zhang, Huang, Walsh: Modulation of DRAK2 autophosphorylation by antigen receptor signaling in primary lymphocytes. in The Journal of biological chemistry 2007
A significant interaction between variants in STK17B and PAX8 (zeige PAX8 Antikörper), in papillary thyroid cancer susceptibility, is reported.
ChIP assays showed that in U937 cells MYB (zeige MYB Antikörper) binds to a conserved element upstream of the DRAK2 transcription start site.
DRAK2 protein directly binds to the type I TGF-beta (zeige TGFB1 Antikörper) receptor and Knockdown of DRAK2 suppresses the tumorigenic ability of breast cancer cells.
DRAK2 and protein kinase D (zeige PRKD1 Antikörper) form a novel signaling module that controls calcium homeostasis following T cell activation.
DRAK2 kinase activity is regulated in a calcium-dependent manner and that Ser (zeige SIGLEC1 Antikörper)(12) phosphorylation is necessary for optimal suppression of T cell activation by this kinase
Strong suppression of T cell receptor signals during thymic selection caused by ectopic DRAK2 expression in a DRAK2 transgenic mouse model of autoimmune encephalomyelitis alters the responsiveness of peripheral T cells.
Regulation of the apoptosis-inducing kinase DRAK2 by cyclooxygenase-2 (zeige PTGS2 Antikörper) in colorectal cancer.
Data provide insight into the role of Drak2 in autoimmune diseases by showing that Drak2 may not suppress TGF-beta (zeige TGFB1 Antikörper) signaling in T cells, and therefore may contribute to autoimmune disease via other molecular pathways.
results demonstrate that DRAK2 plays an important role in primary and memory T cell responsiveness to allografts
T cells from Drak2(-/-) mice exhibited enhanced sensitivity to T cell receptor-mediated stimulation with a reduced requirement for costimulation
DRAK2 transduces non-apoptotic signals during thymocyte differentiation.
Drak2 expresses in the T cell compartment but is not T cell-specific; it plays critical roles in T cell apoptosis and memory T cell development
DRAK2 may be a novel target for stimulating protective immunity to viral pathogens
DRAK2 may have a role in regulating the GC reaction and the response to thymus-dependent antigens, and DRAK2-deficiency is not involved in regulating intrinsic B-cell apoptosis.
reduced viral load in the brains of Drak2(-/-) mice
over-expression causes apoptosis-like cell death which is dependent on the kinase activity
serine/threonine-protein kinase 17B
, serine/threonine kinase 17b (apoptosis-inducing)
, serine/threonine kinase 17b
, serine/threonine kinase 17B
, serine/threonine-protein kinase 17B-like
, DAP kinase-related apoptosis-inducing protein kinase 2
, death-associated protein kinase-related 2